✦ LIBER ✦

Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis

✍ Scribed by Richard Eastell; David M. Reid; Slobodan Vukicevic; Kristine E. Ensrud; Andrea Z. LaCroix; John R. Thompson; David D. Thompson; Steven R. Cummings

Book ID: 116325120
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 448 KB
Volume: 50
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2012.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effect of Denosumab on Bone Turnover

The Effect of Denosumab on Bone Turnover Markers (BTM) in Postmenopausal Women With Osteoporosis

✍ Steven Cummings; Andrea Wang; Javier San Martin; Mike McClung; Christiansen Clau 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Effects of denosumab on bone turnover ma

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

✍ Richard Eastell; Claus Christiansen; Andreas Grauer; Stepan Kutilek; Cesar Liban 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 272 KB 👁 1 views

## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumab‐treat

Effect of Vitamin D Therapy on Bone Turn

Effect of Vitamin D Therapy on Bone Turnover Markers in Postmenopausal Women with Osteoporosis and Osteopenia

✍ Tanzy, Margaret; Camacho, Pauline 📂 Article 📅 2011 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 643 KB

Denosumab treatment for 6 years in

Denosumab treatment for 6 years in postmenopausal women with osteoporosis: The first 3 years of the freedom extension

✍ D. Mellström⁎; J. Brown; H. Bone; R. Chapurlat; N. Franchimont; M. Brandi; E. Cz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Effects of alendronate and risedronate o

Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis

✍ Aysegul Atmaca; Olcay Gedik 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 279 KB

Short-Term Risedronate Treatment in Post

Short-Term Risedronate Treatment in Postmenopausal Women: Effects on Biochemical Markers of Bone Turnover

✍ L. Raisz; J.-A. Smith; M. Trahiotis; P. Fall; K. Shoukri; J. DiGennaro; N. Sacco 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 90 KB

Effects of 3&#xa0;years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis

Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis